Correlation Between BioLine RX and Compugen
Can any of the company-specific risk be diversified away by investing in both BioLine RX and Compugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLine RX and Compugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLine RX and Compugen, you can compare the effects of market volatilities on BioLine RX and Compugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLine RX with a short position of Compugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLine RX and Compugen.
Diversification Opportunities for BioLine RX and Compugen
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BioLine and Compugen is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding BioLine RX and Compugen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compugen and BioLine RX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLine RX are associated (or correlated) with Compugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compugen has no effect on the direction of BioLine RX i.e., BioLine RX and Compugen go up and down completely randomly.
Pair Corralation between BioLine RX and Compugen
Assuming the 90 days trading horizon BioLine RX is expected to under-perform the Compugen. In addition to that, BioLine RX is 1.78 times more volatile than Compugen. It trades about -0.27 of its total potential returns per unit of risk. Compugen is currently generating about 0.13 per unit of volatility. If you would invest 55,360 in Compugen on December 2, 2024 and sell it today you would earn a total of 15,760 from holding Compugen or generate 28.47% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
BioLine RX vs. Compugen
Performance |
Timeline |
BioLine RX |
Compugen |
BioLine RX and Compugen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioLine RX and Compugen
The main advantage of trading using opposite BioLine RX and Compugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLine RX position performs unexpectedly, Compugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will offset losses from the drop in Compugen's long position.BioLine RX vs. Evogene | BioLine RX vs. Enlivex Therapeutics | BioLine RX vs. Kamada | BioLine RX vs. Compugen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |